Medications

FDA approves first liquid, nonstimulant ADHD treatment

The U.S. Food and Drug Administration has approved Tris Pharma's once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD).

Attention deficit disorders

Link between prenatal drug use and ADHD

Prenatal use of alcohol, tobacco and cannabis has all been independently associated with adverse health impacts on the baby. But many people who use these substances during pregnancy aren't using them in isolation.

page 1 from 1